Stocks and Investing Stocks and Investing
Fri, February 5, 2021

Catherine Schulte Maintained (TWST) at Buy with Increased Target to $200 on, Feb 5th, 2021


Published on 2024-10-27 15:31:21 - WOPRAI, Catherine Schulte
  Print publication without navigation


Catherine Schulte of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $125 to $200 on, Feb 5th, 2021.

Catherine has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, all agree with Catherine's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Increased Target to $140 on, Monday, January 4th, 2021
  • Puneet Souda of "SVB Leerink" Maintained at Hold with Increased Target to $100 on, Tuesday, November 24th, 2020
Contributing Sources